Edge Rewrite
restyle Source code View original
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

TFMBOX

Add links
From Wikipedia, the free encyclopedia
(Redirected from IBOX)

TFMBOX
Clinical data
Other names"Compound 5c"
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
Identifiers
  • 7-methoxy-8-(trifluoromethyl)-2,3,4,5-tetrahydro-1-benzoxepin-4-amine
CAS Number
Chemical and physical data
FormulaC12H14F3NO2
Molar mass261.244 g·mol−1
3D model (JSmol)
  • COc1cc2CC(N)CCOc2cc1C(F)(F)F
  • InChI=1S/C12H14F3NO2/c1-17-11-5-7-4-8(16)2-3-18-10(7)6-9(11)12(13,14)15/h5-6,8H,2-4,16H2,1H3
  • Key:NAOXZRLWFAOHAP-UHFFFAOYSA-N

TFMBOX is a putative serotonergic psychedelic of the phenethylamine and benzoxepin ("BOX") families.[1][2][3] It is the cyclized phenethylamine analogue of DOTFM and 2C-TFM in which the α carbon has been connected to the 2-methoxy group via an ethyl chain to form a benzoxepin ring system.[1][2]

Interactions

[edit]

Pharmacology

[edit]

Pharmacodynamics

[edit]

The drug was assessed at and showed affinity for the serotonin 5-HT2A and 5-HT1A receptors, with Ki values of 340 nM and 1,300 nM, respectively.[2] Its affinity for the serotonin 5-HT2A receptor was about 15-fold lower than that of DOB and DOI, whereas its affinity for the serotonin 5-HT1A receptor was the same as that of DOI and was about half that of DOB.[2] TFMBOX also very weakly inhibited the reuptake of serotonin (IC50Tooltip half-maximal inhibitory concentration = 9,900 nM), but did not affect dopamine or norepinephrine reuptake (IC50 = >50,000–100,000 nM).[2] The drug fully substituted for LSD in rodent drug discrimination tests, albeit with about one-third of the potency of DOB and 2C-B.[2]

Chemistry

[edit]

Analogues

[edit]

Other "BOX" drugs that have been assessed include BOX (the cyclized analogue of 2C-H and DOH), BBOX (the cyclized analogue of 2C-B and DOB), and IBOX (the cyclized analogue of 2C-I and DOI).[2][3] However, BBOX and IBOX only partially substituted for LSD in drug discrimination tests.[2][3][4]

History

[edit]

TFMBOX was first described in the scientific literature by Nicholas Cozzi, a student of David E. Nichols, by 1994.[2][3]

See also

[edit]

References

[edit]
  1. 1 2 Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. pp. 852–853. ISBN 978-3-03788-700-4. OCLC 858805226. Retrieved 31 January 2025.
  2. 1 2 3 4 5 6 7 8 9 Monte AP, Marona-Lewicka D, Cozzi NV, Nelson DL, Nichols DE (1995). "Conformationally Restricted Tetrahydro-1-Benzoxepin Analogs of Hallucinogenic Phenethylamines". Medicinal Chemistry Research. 5 (651–663).
  3. 1 2 3 4 Cozzi NV (1994). Pharmacological studies of some psychoactive phenylalkylamines: Entactogens, hallucinogens, and anorectics (Ph.D. thesis). University of Wisconsin, Madison. Retrieved 15 April 2025.
  4. ↑ Monte AP (August 1995). Structure-activity relationships of hallucinogens: Design, synthesis, and pharmacological evaluation of a series of conformationally restricted phenethylamines (Ph.D. thesis). Purdue University. Retrieved 15 April 2025.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=TFMBOX&oldid=1355135756#Analogues"